Package 68071-2890-3

Brand: bupropion hydrochloride sr

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68071-2890-3
Digits Only 6807128903
Product NDC 68071-2890
Description

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-2890-3)

Marketing

Marketing Status
Marketed Since 2022-11-30
Brand bupropion hydrochloride sr
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3d467f93-7a6d-216f-e063-6394a90a0168", "openfda": {"upc": ["0368071289039"], "unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["eeb3fed1-2202-09fc-e053-2995a90a9f63"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-2890-3)", "package_ndc": "68071-2890-3", "marketing_start_date": "20221130"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-2890-6)", "package_ndc": "68071-2890-6", "marketing_start_date": "20250826"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "68071-2890_3d467f93-7a6d-216f-e063-6394a90a0168", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68071-2890", "generic_name": "bupropion hydrochloride", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20180420", "listing_expiration_date": "20261231"}